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Abstract 
This is a two-part study of perimenstrual symptomatology in Chinese women. We 
developed and validated the Chinese Questionnaire of Perimenstrual Symptoms (CQ-
PERI-MS), which was adapted from the Moos Menstrual Distress Questionnaire, and 
used this instrument to assess the prevalence and nature of perimenstrual symptoms 
among Chinese women in Hong Kong. The initial CQ-PERI-MS was first 
administered to a sample of 538 menstruating Chinese women in Hong Kong together 
with measures of anxiety, depression, and neuroticism. Psychometric analyses 
rendered a 32-item final CQ-PERI-MS which demonstrated good reliability, 
convergent and discriminant validity, and factorial validity. Factor analysis yielded 
four factors, namely, Dysphoria, Somatic Distress, Cognitive Problems, and Arousal. 
The CQ-PERI-MS was then administered to a separate sample of 339 menstruating 
Chinese women in Hong Kong for further examination of validity as well as pattern 
of perimenstrual symptoms. It was found that perimenstrual symptoms were common, 
with 18.6% and 34.2% of the participants reporting ten or more premenstrual and 
menstrual symptoms respectively. Both premenstrual and menstrual distress were 
characterized by a combination of emotional and somatic symptoms. Contrary to 
previous preconceptions, perimenstrual symptoms are commonly experienced by 
Chinese women, with both overlapping and distinct features as compared to patterns 
in the West. 
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Introduction 
The recurrent nature of menstruation-related changes and its potential impact 
on the daily lives of women and their significant others makes premenstrual and 
menstrual symptoms (perimenstrual symptoms, PERI-MS) a central issue in the well-
being of modern women. While both professional and lay interest in premenstrual 
syndrome (PMS) has burgeoned in recent years, menstrual distress was largely 
neglected except for dysmenorrhea. Nevertheless, there is evidence that other 
symptoms might occur during the menstrual phase, including psychological 
symptoms such as depressed mood, irritability, and anxiety, and somatic symptoms 
such as fatigue, nausea, and headache [1-3]. Bancroft also urged for a broader 
conceptualization of perimenstrual problems that included symptoms in both the 
premenstrual and menstrual phases [4,5]. Despite increasing awareness of the 
importance of menstrual complaints, the exact nature of these complaints is not well 
characterized. Knowledge of PERI-MS among non-Western women is even more 
lacking, as Johnson [6] and subsequent researchers [7,8] argued that PMS is a Western 
“culture-bound syndrome”. However, there are emerging reports of PMS and its more 
severe form, Premenstrual Dysphoric Disorder (PMDD), in different non-Western 
societies including India [9,10], China [11-14], Japan [15], Thailand [16] and Africa 
[17], suggesting that premenstrual symptoms are also common among non-Western 
women. Nonetheless, as cultural beliefs are associated with both expectations about 
menstrual cycles and perimenstrual symptoms [18], perimenstrual symptoms do differ 
across cultures, in terms of prevalence and symptom patterns [18-22].  
Indeed, existing studies showed the pattern of perimenstrual symptoms seem 
to differ from that depicted among Western women [18-22]. A study of Hong Kong 
females showed that they were more likely to experience premenstrual fatigue and 
pain and less likely to experience premenstrual negative affect than Western women 
[22]. Another study of females in China also showed that premenstrual complaints 
were predominantly somatic, such as fatigue, hypersomnia, and abdominal pain [23].   
More detailed knowledge of the exact nature of premenstrual complaints among 
Chinese women is, however, not available. Knowledge of Chinese women’s 
experiences during the menstrual phase is even more lacking but one study revealed 
that over 60% of Chinese women reported negative physical, psychological, and 
behavioral changes during the menstrual phase [23], documenting the significance of 
the problem. Better characterization of both premenstrual and menstrual complaints 
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among Chinese women is definitely warranted.  
There is a general lack of research on PERI-MS in Chinese women, as 
menstruation is still a “taboo” in Chinese culture. More importantly, a valid Chinese 
research instrument for measuring PERI-MS is not available. Previous studies mainly 
involved very small samples and used instruments derived from the West that were 
not properly tested for their cultural validity.  A previous study translated the widely 
used Moos Menstrual Distress Questionnaire [MDQ, 24] into Chinese and reported 
reasonable internal consistency of the Chinese version [22]. However, the issues of 
factor structure and cultural equivalence, particularly as it related to culturally specific 
ways of describing premenstrual and menstrual complaints, were not addressed. In 
other words, the Chinese MDQ demonstrated reliability but questionable validity. 
Cultural validity requires an instrument to accurately and adequately measure the 
condition under study in a particular cultural group.  As perimenstrual experiences are 
shaped by cultural beliefs [18], PERI-MS is expected to differ across cultures.  The 
Western-derived MDQ was constructed based on perimenstrual symptoms reported by 
women living in the West. Moos compiled the list of symptoms in the MDQ through 
interviewing women in a Western university in USA of their perimenstrual 
experiences and literature review [24].  Ethnicity of the participants was not reported 
and there was no indication that it was a culturally diverse group.  It is possible that 
the list of symptoms included in the MDQ may not capture the full range of 
perimenstrual symptoms experienced by Chinese women, thus underestimating the 
prevalence of perimenstrual distress of Chinese women. A culturally sensitive 
instrument that captures the full range of symptoms experienced by Chinese women is 
needed.  As Kleinman [25] urged, culturally sensitive research should go beyond the 
direct imposition of Western constructs on non-Western contexts in which they might 
lack validity. In order to derive a locally valid research instrument, complementary 
"etic" (culture-universal) and "emic" (culture-specific) items should be integrated to 
form an item pool for validity and reliability analysis. Thus, the development of a 
culturally sensitive instrument for assessing perimenstrual symptoms among Chinese 
women should start with an understanding of the perimenstrual experiences as 
described by Chinese women, through qualitative research approaches such as 
interviews with Chinese women. It is envisioned that this instrument would include 
universal symptoms that are experienced by both Western and Chinese women, as 
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well as culturally distinct symptoms that are only salient among Chinese women. This 
instrument also needs to be formally tested for reliability and validity. Without such a 
culturally valid instrument for measuring PERI-MS among Chinese women, any 
effort to examine the nature of PERI-MS among Chinese women or to compare PERI-
MS between Chinese and Western women is dangerous.  
Given preliminary evidence of both premenstrual and menstrual complaints 
among Chinese women, it is of both scientific and clinical relevance to further our 
understanding of the exact nature of these problems among Chinese women. However, 
validity of these attempts depends on the availability of a culturally valid instrument 
for measuring premenstrual and menstrual complaints among Chinese women. Thus, 
the objectives of the present study are to develop a research instrument that can 
validly measure PERI-MS among Chinese women, and to use it to examine the 
prevalence and pattern of PERI-MS among Chinese women in Hong Kong. Results 
will provide much needed data on perimenstrual experience of Chinese women, and 
facilitate the development of culturally sensitive research criteria of PERI-MS. In 
addition, this instrument can, in the future, be used on Western women to examine the 
universal and culture-specific aspects of PERI-MS.  
The study consisted of two parts: Study 1 focused on the development and 
validation of the Chinese Questionnaire of Perimenstrual Symptoms (CQ-PERI-MS) 
while Study 2 aimed at confirming the factor structure of the CQ-PERI-MS derived in 
Study 1 and using the validated CQ-PERI-MS to examine the pattern of perimenstrual 
symptoms.  
 
STUDY 1 
Methods 
Participants 
The study was approved by the local institutional review board. Informed 
consent was sought from all participants. A convenience sample of 700 Chinese 
women in Hong Kong was recruited to participate in the study. Inclusion criteria were 
ethnic Chinese females between 15 and 55 with regular menstruation. Women who 
were pregnant, menopausal or amenorrhoeic for other reasons were excluded. A total 
of 538 women returned the completed questionnaires, yielding a response rate of 
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76.9%. 
 
Development of the CQ-PERI-MS 
The CQPERI-MS was developed from the 47-item Moos Menstrual Distress 
Questionnaire [MDQ; 24]. The MDQ is a widely used instrument for assessing 
premenstrual and menstrual emotional, somatic and behavioural changes.  In the 
original MDQ, participants were asked to rate the degree to which they experience 
each of the 47 symptoms on a six-point scale from 1 (no experience of the symptom) 
to 6 (acute or partially disabling experience of the symptom), separately for the 
premenstrual, menstrual, and intermenstrual phases. Premenstrual and menstrual 
changes can then be derived through subtracting intermenstrual scores from 
premenstrual and menstrual scores respectively. Eight factors were extracted through 
factor analysis, representing eight clusters of symptoms which were labelled pain, 
concentration, behavioural change, autonomic reactions, water retention, negative 
affect, arousal, and control [24]. The first six factors represented distressing 
symptoms while arousal referred to positive experiences such as burst of energy and 
feelings of well-being. The control factor was included to control for tendency to 
report symptoms regardless of whether they were related to the menstrual cycle, and 
included symptoms such as “buzzing or ringing in ears” which were not associated 
with perimenstrual distress.         
To complement the list of perimenstrual symptoms characteristic of Western 
women as depicted in the MDQ, a list of common premenstrual and menstrual 
symptoms experienced by Chinese women were elicited through semi-structured 
focus group interviews with menstruating Chinese women conducted by the first 
author. The aim and format of the interviews were explained to the participants. 
Confidentiality and anonymity were ensured, and informed consent was obtained. 
Participants were invited to describe physical, emotional and behavioral changes they 
experienced in the seven to ten days before menstruation and during the days of 
menstrual flow. They were encouraged to speak about their experiences freely. Each 
focus group lasted about 1.5 hours. Consecutive groups of women were interviewed 
until data saturation was achieved. Data saturation is a well established principle in 
qualitative research and refers to termination of data collection when information 
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from participants becomes repetitive and additional interviews do not contribute 
significant additional information [26,27]. Based on this principle, three focus group 
interviews with a total of fourteen Chinese women of diverse age groups and 
backgrounds were conducted. One focus group included adolescent schoolgirls, 
another included undergraduate and graduate females, and the final one included 
working women and housewives. The participants described a mixture of symptoms 
commonly included in Western instruments as well as symptoms that were rarely 
assessed in Western instruments, such as “paleness”, “body dissatisfaction”, and 
“worrisome”. The latter was regarded as locally derived items. A list of 20 locally 
derived items were complied and added to the 47-tiem MDQ to form the 67-item CQ-
PERI-MS. This enlarged the scope of symptoms surveyed by taking account of the 
more locally relevant idioms of distress. It was hoped that the resultant CQ-PERI-MS 
could better capture the full range of perimenstrual symptoms experienced by 
Chinese women in Hong Kong, and thus be more culturally sensitive.  
The psychometric properties of the CQ-PERI-MS, including its factor 
structure, internal reliability, and convergent and discriminant validity, were examined. 
Factor structure of the CQ_PERI_MS was examined using exploratory factor analysis. 
Internal reliability was assessed in terms of internal consistency. In psychometric 
testing, convergent and discriminant validity is assessed through examination of the 
relationship between the measure under study (CQ-PERI-MS) and measures of 
related variables that the construct is expected to have relationship with [28,29]. 
Convergent validity is evidenced when the measure under study is significantly 
correlated with measures which it theoretically is expected to be strongly associated 
with, such as measures of its established correlates.  Discriminant validity refers to 
the measure of the construct being distinct from other measures that it is related with 
but theoretically distinct from. It is evidenced by the measure being not highly 
correlated with measures of related variables. In other words, it is a demonstration of 
the measure’s uniqueness. In the current study, convergent and discriminate validity 
of the CQ-PERI-MS was examined with respect to its relationship with measures of 
anxiety, depression, and neuroticism as these are documented to be significant 
correlates of premenstrual and menstrual complaints [17,30-32] while being 
characteristics that are theoretically distinct from premenstrual and menstrual 
complaints.  We hypothesized that perimenstrual symptoms as measured by the CQ-
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PERI-MS were positively and significantly related to anxiety, depression, and 
neuroticism but the correlations would only be moderate in strength. 
 
Other Measures 
Chinese Questionnaire of Perimenstrual Symptoms (CQ-PERI-MS) 
The 20 locally derived items elicited from the focus group interviews were added to 
MDQ to form the 67-item CQ-PERI-MS. Participants were asked to rate the severity 
of each symptom on a 6-point scale, based on experiences in the previous six months. 
The severity of each symptom was rated separately for premenstrual, menstrual, and 
intermenstrual phases. Higher scores represent greater severity of symptoms. 
 
Hospital Anxiety and Depression Scale [HADS; 33,34]  
Anxiety and depression were assessed by the validated Chinese version of the 
Hospital Anxiety and Depression Scale [HADS; 33,34].  The HADS is a 14-item self-
report instrument with two separate subscales for assessing depressive and anxiety 
symptoms among medical patients and the general population.  Participants were 
asked to rate the degree to which they agree to each of the 14 statements that describe 
the symptoms using a four-point scale. Higher scores indicated higher levels of 
anxiety or depression. 
 
Neuroticism Subscale of the Eysenck Personality Inventory [N-EPI; 35] 
Neuroticism was measured by the Neuroticism subscale of the Eysenck Personality 
Inventory [35]. This 12-item subscale measures an individual’s neurotic personality 
traits. Participants were asked to rate whether or not each statement was true of their 
feelings and behaviors. The total number of “yes” items represented the participant’s 
Neuroticism score.  Higher scores indicated higher levels of neuroticism.  
  
 
Results 
The demographic and menstrual characteristics of the sample in Study 1 are 
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presented in Table 1. The mean age of the sample was 20.18 [SD=7.17]. Most of the 
participants were single (92.4%). 
Insert Table 1 about here 
Exploratory factor analysis (EFA) using principal axis factoring and varimax 
rotation was performed on the initial 67-item CQ-PERI-MS, separately for the 
premenstrual and the menstrual phases. Only items with factor loadings greater 
than .40 on the same factor for both phases were included into a factor to make the 
resultant factor structure applicable to both the premenstrual and menstrual phases.  
Since the original MDQ had eight factors, an eight-factor solution was fitted 
into exploratory factor analysis (EFA) using principal axis factoring and varimax 
rotation but the structure was not interpretable. Scree plot and eigenvalues suggested 
an optimal number of four factors but two to five factor solutions were also fitted to 
identify the most interpretable structure. Factor solutions showed that the four-factor 
structure was the most interpretable and parsimonious structure. Thirty-two items 
with factor loadings greater than .40 for both phases yielded the final CQ-PERI-MS. 
Table 2 shows the factor structure, composition, and loadings of the final CQ-
PERI-MS. Factor 1 was labeled Dysphoria, and consisted of 15 items of negative 
emotional states. Factor 2 was labeled Somatic Distress, and included nine items of 
physical symptoms. Factor 3 was labeled Cognitive Problems, and consisted of three 
items describing states of confusion and a lack of clarity of mind. The final factor was 
labeled Arousal, and included five items on various positive states such as excitement. 
Twelve of the twenty locally derived items loaded saliently on one of the four factors 
of the CQ-PERI-MS. All of them loaded either on the Dysphoria or the Somatic 
Distress factors, showing the prominence of these symptoms among Chinese women. 
The four factors together accounted for a total of 60.3% and 57.6% of variances in 
premenstrual and menstrual phases, respectively.  
Factor analysis of scores in the intermenstrual phase did not yield any 
interpretable structure using the eight factor solution or the two- to five-factor 
solutions. An examination of the scree plot and eigenvalues suggested a fourteen 
factor solution which did not make any conceptual sense. This showed that the 
symptom ratings in the intermenstrual phase did not fall into any meaningful pattern, 
thereby contributing to the construct validity of the final 32-item CPDQ. 
Insert Table 2 about here 
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Reliability, in terms of internal consistency, was high for the four factors in 
both the premenstrual and the menstrual phases. Cronbach’s alphas for the Dysphoria, 
Somatic Distress, Cognitive Problems, and Arousal subscales were .96, .92, .89, 
and .80 respectively in the premenstrual phase, and .96, .78, .89, and .78 respectively 
in the menstrual phase.  
MANOVAs revealed that those who were menstruating at the time of filling 
out the questionnaires did not differ significantly on reported premenstrual symptoms 
(Wilks  = .98, F4 = 0.80, P = .384) or menstrual symptoms (Wilks  = .97, F4 = 
2.01, P = .094) from those who were not. As a result, the two groups were collapsed 
in subsequent analyses. 
Mean factor scores for premenstrual, menstrual, and intermenstrual phases 
were presented in Table 3. Subsequent paired t-tests showed evidence of premenstrual 
and menstrual distress, as there were significant increases in symptom severity in 
Dysphoria (t534 = 14.36, p < .001) , Somatic Distress (t534 = 14.62, p < .001), and 
Cognitive Problems (t532 = 6.07, p < .001), but decreases in Arousal (t530 = -7.78, p 
< .001) between the premenstrual and intermenstrual phases and between the 
menstrual and intermenstrual phases (Dysphoria: t534 = 21.73, p < .001; Somatic 
Distress: t534 = 26.86, p < .001; Cognitive Problems: t532 = 9.41, p < .001; Arousal: 
t530 = -10.62, p < .001).  
Insert Table 3 about here 
To examine the convergent and discriminant validity of the CQ-PERI-MS, 
Pearson r correlation analyses with Bonferroni correction were conducted to 
determine associations among premenstrual symptoms, menstrual symptoms, anxiety, 
depression, and neuroticism. Results are shown in Table 4. The correlation 
coefficients were in the expected pattern, with premenstrual and menstrual Dysphoria, 
Somatic Distress, and Cognitive Problems being significantly but not strongly 
correlated with anxiety, depression, and neuroticism, providing evidence of 
convergent and discriminant validity.  
Insert Table 4 about here 
 
STUDY 2 
Methods 
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Participants and Procedures 
The final CQ-PERI_MS was administered to a separate sample of Chinese 
females in Study 2 to confirm the factor structure derived in Study 1, and to examine 
the pattern of perimenstrual symptoms. Inclusion and exclusion criteria were the same 
as in Study 1. As in Study 1, confidentiality was assured and informed consent was 
sought prior to participation. Five hundred questionnaires were administered to a 
community sample of Hong Kong Chinese women. A total of 339 valid 
questionnaires were received, yielding a response rate of 67.8%. 
  
Results 
The mean age of the participants in Study 2 was older than that in Study 1 
(37.28±9.39 vs 20.18±7.17, p < .001) with a range of 18 to 50. Participants in Study 2 
were also more diverse in terms of marital status. The majority of them were married 
(69%) with 26.8% being single, and 4.1% being separated, divorced or widowed. The 
majority of the women (83%) were engaged in paid employment. Their menstrual 
cycle characteristics were similar to those of participants in Study 1. The mean length 
of the menstrual cycle was 29.14 days (SD = 2.83) and the mean number of days of 
menstrual flow was 5.63 days (SD = 1.38). The majority of the participants (72%) 
were not taking contraceptive pills. 
 Confirmatory factor analyses (CFA) were performed using the EQS 
Programme to determine whether the data fitted the four-factor structure identified. 
For the premenstrual phase, the model fit was marginally satisfactory as shown by 
various goodness of fit indices (NFI = .74, NNFI = .76, CFI = .78, IFI = .78, 
standardized RMR =.08, RMSEA = .11). As modifications suggested by the LM test 
did not improve the model, the original model was retained. Similarly, the model fit 
for the menstrual phase was also marginally satisfactory (NFI = .74, NNFI = .78, CFI 
= .80, IFI = .80, standardized RMR = .07, RMSEA = .10). Reliability in terms of 
internal consistencies of factors were good, with the Cronbach’s alphas for the 
Dysphoria, Somatic Distress, Cognitive Problems and Arousal subscales 
being  .96, .89, .77, and .75 respectively for the premenstrual phase and .96, .89, .79, 
and .77 respectively for the menstrual phase.  
The relationship between age and CQ-PERI-MS subscale scores were 
examined. Independent t-tests with Bonferroni correction were conducted. 
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Participants aged 30 or above were not significantly different from those below 30 on 
any of the four premenstrual subscale scores. However, participants aged 30 or above 
had significantly higher menstrual Dysphoria scores (mean = 0.60, SD = 0.64) 
compared to those below 30 (mean = 0.31, SD = 0.47, p = .000). No significant 
differences were found for the other subscales.     
The percentage of participants reporting premenstrual and menstrual 
symptoms is shown in Table 5. A total of 18.6 % reported ten or more premenstrual 
symptoms while 34.2% reported ten or more menstrual symptoms. In general, 
menstrual symptoms were more frequently reported than premenstrual ones. Table 6 
shows the percentage of participants reporting each of the 32 premenstrual and 
menstrual symptoms. There were both overlaps and differences in the most frequently 
reported symptoms in the two phases.  The most frequently reported premenstrual 
symptom was irritability (39.9%), followed by fatigue (36.4%) and stomachache 
(36.2%) while the most commonly reported menstrual symptom was fatigue (62.0%), 
followed by abdominal cramps (60.6%) and irritability (54.4%). 
 Insert Table 5 about here   
Insert Table 6 about here 
Mean factor scores for the premenstrual, menstrual, and intermenstrual phases 
are shown in Table 7. Repeated Measures ANOVAs comparing subscale scores across 
the three phases were conducted. Results demonstrated significant overall differences 
in Dysphoria (F2,562 = 101.14, p < 0.001), Somatic Distress (F2,574 = 181.00, p < .001), 
Cognitive Problems (F2,558 = 27.45, p < 0.001), and Arousal (F2,540 = 27.52, p < 0.001) 
across the phases. Planned post hoc comparisons showed evidence of premenstrual 
and menstrual distress, as well as menstrual exacerbation of premenstrual distress. 
There were significant increases in Dysphoria (t282 = 8.93, p < 0.001; t281 = 12.59, p < 
0.001), Somatic Distress (t287 = 10.19, p < 0.001; t287 = 16.18, p < 0.001), and 
Cognitive Problems (t280 = 3.75, p < 0.001; t279 = 6.11, p < 0.001) in the premenstrual 
and the menstrual phases compared to the intermenstrual phase. Moreover, Dysphoria 
(t290 = 5.25, p < 0.001), Somatic Distress (t297 = 11.07, p < 0.001), and Cognitive 
Problems (t281 = 4.93, p < 0.001) were all significantly higher in the menstrual phase 
than in the premenstrual phase. Arousal decreased in both the premenstrual (t532 = -
7.78, p < 0.001) and menstrual (t530 = -10.62, p < 0.001) phases, and was higher in the 
premenstrual phase than in the menstrual phase (t530 = -6.03, p < 0.001). 
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Insert Table 7 about here 
Discussion 
 The present study represents an effort to develop a locally valid and reliable 
instrument for measuring perimenstrual symptoms among Chinese women, and to use 
this instrument to better understand their perimentstrual distress. Previous studies in 
the area were seriously limited by the fact that instruments used were simply 
translated from the West which might not validly measure perimenstrual symptoms 
among Chinese women. The construction of the Chinese Questionnaire of 
Perimenstrual Symptoms (CQ-PERI-MS), based on a widely used Western instrument 
supplemented by local items, took on a culturally sensitive approach that aimed to 
overcome the problem.  The CQ-PERI-MS was found to have good reliability in both 
the premenstrual and menstrual phases in Study 1 as well as in Study 2. Its factorial 
validity was supported by the interpretable four-factor structure derived in Study 1 
which was confirmed in Study 2. Chinese women’s perimenstrual experiences were 
characterized by four dimensions. Arousal represented more positive experiences 
while Dysphoria, Somatic Distress, and Cognitive Problems represented more 
negative experiences. Although the eight-factor structure of the MDQ [24] failed to be 
replicated among Chinese women, the content of the Dysphoria, Cognitive Problems, 
and Arousal subscales of the CQ-PERI-MS were highly similar to Moos’ Negative 
Affect, Concentration, and Arousal subscales respectively. The Somatic Distress 
subscale of the CQ-PERI-MS included items that were distributed among Moos’ Pain, 
Autonomic Reactions, and Behavioral Change subscales. This interesting finding 
suggests that Chinese women’s perimenstrual distress is probably less elaborated than 
that of their Western counterparts. Various forms of physical discomfort appeared to 
be interfused in the experience of Chinese women. Women in Moo’s study [24] 
experienced three distinct dimensions of somatic and behavioral symptoms (pain, 
autonomic reactions, and behavioral change) but somatic and behavioral symptoms of 
Chinese women in our study constituted one single factor which we labeled as 
Somatic Distress.  This factor included a mixture of pain, autonomic and general 
physical symptoms as well as behavioral change. Different categories of somatic 
distress are experienced as a single entity by Chinese women.  It is not entirely clear 
why this is so but one possibility is that traditional Chinese beliefs on health and well-
being might have mediated Chinese women’s perimenstrual experiences. As 
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suggested by different researchers, perimenstrual experiences are shaped by cultural 
beliefs [8, 18]. The fact that different categories of somatic symptoms were 
experienced holistically as a single dimension of somatic distress among Chinese 
women appears to be very much in line with Traditional Chinese Medicine’s 
conceptualization of health and illness. Instead of adopting an anatomical model of 
the body as in Western medicine, Traditional Chinese Medicine adopts a functional 
model, with the body conceptualized as an integrated whole and the function of all 
organs being interconnected, resulting in problem in one organ affecting the 
functioning of all other organs [36,37].  Health is conceptualized as the result of 
harmonious balance among interconnected systems of the body, and disease as a 
result of disruptive imbalance. According to Traditional Chinese Medicine, 
premenstrual symptoms are caused by Liver qi stagnation (or stagnated flow of vital 
energy of Liver) that affects multiple systems and organs [36,38]. Chinese women’s 
perimenstrual experiences might be shaped by Traditional Chinese perspectives, with 
somatic symptoms relating to different body systems being experienced holistically 
and in an integrated manner as a single entity of physical discomfort. The item “take 
naps, stay in bed” also loaded saliently on the Somatic Distress factor, suggesting that 
the physical symptoms are associated with behavior change in the form of taking naps 
or staying in bed. The factor structure of the MDQ or the modified MDQ (which 
included only the six symptom subscales and excluded the Arousal subscale and the 
Control subscale) has been the subject matter of a number of studies in the literature.  
There is great consistency across studies regarding the Negative Affect and 
Concentration/Cognitive Problems factors. Most studies were able to replicate Moos’ 
study and indicated these two symptom groups as two distinct factors [39-41].  Our 
study adds to this accumulating body of evidence that negative affect and cognitive 
problems constitute two salient groups of perimenstrual problems and confirmed the 
findings of previous studies [24, 39-42] that negative affect and cognitive problems 
constitute two core and independent dimensions of perimenstrual symptoms. The 
main inconsistency appears to be with somatic symptoms. While Moos [24] and Clare 
[39] and more recently, Ross et al. [40], all identified three distinct groups of somatic 
symptoms (pain, water retention, and autonomic reactions), Siegel et al [42] and van 
der Ploeg [41] only identified two distinct somatic factors, labeled as Physical 
Discomfort and Water Retention in Siegel et al’s study [42] and as Pain and Water 
Retention in van der Ploeg’s study [41]among Dutch women.  In our study of Chinese 
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women, somatic distress emerged as a single factor. This points to the possibility of 
cultural variation in perimenstrual symptoms, particularly with respect to somatic 
problems. It also suggested that the MDQ, used without suitable modifications and 
validation, may not be appropriate for women of all cultures.  
Evidence for the construct validity of the CQ-PERI-MS was found in both 
Study 1 and Study 2 of the present study. Dysphoria, Somatic Distress, and Cognitive 
Problems subscale scores were significantly higher in the premenstrual and menstrual 
phases than in the intermenstrual phase, and Arousal subscale score was significantly 
lower in the premenstrual and menstrual phases than in the intermenstrual phase. This 
showed that the CQ-PERI-MS measures dimensions of experience that vary across 
different phases of the menstrual cycle. As no interpretable factor structure could be 
identified for the intermenstrual phase, it provided further evidence that the CPDQ 
measures premenstrual and menstrual distress that is structurally different from that in 
the intermenstrual phase.  
Relationships between CQ-PERI-MS subscale scores and measures of anxiety, 
depression, and neuroticism provided support for the convergent and discriminant 
validity of the CQ-PERI-MS. All the correlation coefficients between the Dysphoria, 
Somatic Distress, and Cognitive Problems subscales on one hand and anxiety, 
depression, and neuroticism on the other were statically significant but in the range of 
0.09 to 0.30 which correspond to a small to medium effect size [43]. This significant 
though modest strength of relationship between CQ-PERI-MS subscales and related 
constructs as hypothesized reflects that the CQ-PERI-MS is measuring symptom 
clusters that are unique and distinct from anxiety, depression and neuroticism but at 
the same time significantly related to these factors. 
The fact that the factor structure and reliability of the CQ-PERI-MS were 
consistent across the two separate samples which were quite different in age and 
marital status supports that it is a valid and reliable measure of perimenstrual 
symptoms among Hong Kong women in general. 
The present study demonstrated the usefulness of integrating locally derived 
items with those drawn from existing research instruments [44,45]. This approach to 
research in non-Western populations is superior to the straightforward deletion of 
useless items from a standard Western questionnaire [46]. Many of the locally derived 
items, for example, worrisome, paleness, body dissatisfaction, weakness, and fault-
finding had high endorsement frequency and loaded saliently on the four factors. This 
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showed that the local items are prominent and constitute an indispensable part of the 
Chinese perimenstrual experience. Failure to include these items would lead to a 
falsely low prevalence of perimenstrual distress among Chinese women, as well as 
limit our understanding of the complete spectrum of perimenstrual symptoms among 
these women.  
It is noteworthy that many of these locally derived items are culturally 
sensitive but not culturally specific. Indeed, some of these items do overlap with 
items on measures of premenstrual symptoms in the West. For example, the 95-item 
Western derived Premenstrual Assessment Form [PAF; 47] also consists of an item on 
feelings of weakness. The locally derived items “worrisome” and “body 
dissatisfaction” are also similar to though not exactly the same as the items 
“pessimistic outlook” and “dissatisfaction with appearance” on the PAF. These 
symptoms are culturally sensitive in describing Chinese women’s perimenstrual 
experiences but are by no means specific to Chinese women. Some locally derived 
items such as “paleness” are quite culturally specific and not found in any of the 
existing Western-derived instruments.  
Even though some of the locally elicited symptoms have some degree of 
overlap with items on the PAF, the significance of these symptoms and the CQ-PERI-
MS should not be seen as being discounted. This is because the PAF is very lengthy 
and is thus not a very practical research instrument. The CQ-PERI-MS is a much 
more concise representation of the range of perimenstrual symptoms experienced by 
Chinese women. Its brevity is important in facilitating further perimenstrual research 
among Chinese women. Another unique significance of the CQ-PERI-MS is that 
while the PAF is only a measure of premenstrual symptoms, the CQ-PERI-MS is a 
measure of both premenstrual and menstrual symptoms. It will serve as an invaluable 
tool in future studies of  perimenstrual distress. 
Although some items on the CQ-PERI-MS such as paleness seem to be very 
culturally specific, this does not preclude the possibility that women in other cultures 
also experience these symptoms. It is plausible that these were not included in 
instruments developed in the West and hence not assessed among Western women. 
Future studies should aim at examining the existence of these symptoms in non-
Chinese women. 
Using the CQ-PERI-MS, the prevalence of perimenstrual distress among 
Chinese women was examined. Nearly one-fifth and more than one-third of our 
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sample of Chinese women experienced ten or more premenstrual and menstrual 
symptoms respectively. This is comparable to the reported prevalence of 
perimenstrual symptoms in Western studies [48]. It is likely that the 2.9% of women 
who experienced more than 20 premenstrual symptoms and the 6.2% who 
experienced more than 20 menstrual symptoms on the in our study actually suffered 
from severe forms of perimenstrual distress and would require treatment. This rough 
estimate is similar to rates found in other studies [48-50]. 
The figures dispel the myth that Chinese women do not suffer from 
perimenstrual distress. It also adds to the accumulating body of evidence that 
perimenstrual distress is a cross-cultural phenomenon [17] rather than a Western 
“culture-bound syndrome”. There are increasing reports of premenstrual complaints 
from urbanized regions of developing countries such as India [9,10], Africa [51] and 
China [11-14], though the reported rates are generally lower than those identified in 
the present study. The use of a culturally valid instrument in the present study might 
have contributed to a more accurate estimation of the prevalence of premenstrual 
symptoms among Chinese women. It also provides much needed information on the 
prevalence of menstrual symptoms among Chinese women.    
Contrary to the widely held notion that Chinese people are not as 
psychologically-minded as their Western counterparts, and tend to “somatize” their 
distress, our findings of the high endorsement frequency of emotional symptoms and 
the fact that Dysphoria emerged as the largest factor might seem surprising. These 
supported the view that somatization in Chinese populations has been over-stated [52]. 
It is also worth noting that diverse emotional states including irritability, anger, 
depressed mood, and anxiety were endorsed by the participants. Irritability was more 
commonly reported premenstrual symptom than depressed mood. The same 
observation was documented in a number of studies among Western women [1,53,54] 
as well as among Indian women [10], Chinese women in Hong Kong [55], and 
African women [51]. In our study, we further found that irritability constitute a core 
emotional symptom in the menstrual phase. Taken together, these findings highlight 
the need to recognize irritability as a core element of perimenstrual emotional distress 
in clinical practice, and the need to include this item in any research instrument 
developed for measuring perimenstrual symptoms.   
Another interesting finding is the prominence of fatigue in both the 
premenstrual (36.4%) and menstrual (62.0%) phases. These rates were higher than 
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those of Indian women [10], African women [51], and women in the USA [56], but 
were in keeping with a previous study of premenstrual symptoms among Chinese 
women in Hong Kong [55] and a local community health survey which revealed that 
71% of women reported frequent fatigue [57]. Our study showed that an appreciable 
portion of women reported exacerbation of fatigue before or during menstruation. The 
salience of this symptom among Chinese women should be given due attention both in 
research and in clinical practice. 
Menstrual distress was shown to be more common than premenstrual ones. 
This affirmed that menstrual distress should not be left out in the study of 
perimenstrual distress, as is the case in the current literature. It also appeared that the 
relationship between menstrual symptoms and the psychological variables of anxiety, 
depression, and neuroticism was much stronger than that between premenstrual 
symptoms and these variables. Taken together, it highlights the significance of 
menstrual distress as an issue that certainly deserves greater research and clinical 
attention. 
Given that the CQ-PERI-MS seems to be culturally sensitive but not 
necessarily culturally specific to Chinese women, future studies could also test its 
validity among Western women. Given that experiences change with time and 
changing social forces, it is in all likelihood that the additional perimenstrual 
symptoms identified in the present study and included in the CQ-PERI-MS represent 
new forms of distress brought about by modernization rather than being due to 
cultural difference per se. Studies aiming to examine cultural myths and attitudes 
towards menstruation, especially as they relate to perception, recognition, and 
reporting of symptoms, should also be encouraged 
Several limitations of the present study need to be highlighted. First, 
convenience sampling limited the generalizability of the findings, and the study 
should be taken as exploratory. Second, Hong Kong women are not representative of 
the whole Chinese female population. Caution should be exercised in extrapolating 
results to Chinese females in other social and cultural settings. Third, data were 
collected from retrospective self-reports. There was no clinical verification of the 
perimenstrual symptoms.  The retrospective nature of the self-report also means that 
the cyclicity of symptom variation, as reported, may be amplified, though it was 
admitted that retrospective reports were reasonably accurate among women who 
experienced moderate or severe symptoms [48]. There is also evidence that the factor 
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structure of perimenstrual distress was stable irrespective of whether the symptoms 
were assessed retrospectively or prospectively [40]. We can, therefore, be reasonably 
confident that despite the retrospective nature of our study, our data adequately 
reflects both the structure and the rates of perimenstrual symptoms among Chinese 
women. Future studies should, however, confirm our findings through the use of 
prospective assessments, supplemented by clinician’s verification of symptom 
severity and functional impairment. 
Notwithstanding these limitations, our study demonstrated the validity and 
reliability of the CQ-PERI-MS in assessing premenstrual and menstrual symptoms 
among Chinese women, and the significance of perimenstrual symptoms among this 
group of women who were once believed to be minimally affected by this problem. It 
also contributes to our understating of the structure of perimenstrual symptoms cross-
culturally. 
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Table 1. Demographic and Menstrual Characteristics of the Sample in Study 1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Values are given as n (%) or mean [SD]. 
Percentages are expressed as valid percentages. 
  
 
 
n = 538 
Age 20.18 [SD=7.17] 
14-18 211 (39.6) 
19-25 262 (49.2) 
26-35 28 (5.2) 
36-45 18 (3.4) 
46 and above 14 (2.6) 
  
Marital status  
Single  489 (92.4) 
Married 39 (7.4) 
Separated/Divorced 1 (0.2) 
  
Menstrual Characteristics  
Age of menarche 12.27 [SD=1.31] 
Length of menstrual cycle 30.58 [SD=5.54) 
Length of menstrual flow 5.73 [SD=1.19] 
  
Taking oral contraceptive   
No 527 (99.4) 
Yes 3 (0.6) 
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Table 2. Factor Structure of the CQ-PERI-MS for Study 1 (n = 538) 
  Salient Factor Loadings 
Premenstrual Menstrual 
Factor 1: Dysphoria 25.0% 27.0% 
 Loneliness   .56 .61 
 Anxiety   
   
.50 .59 
 Irritability   
  
.72 .75 
 Mood swings   
  
.78 .81 
 Depressed mood  
  
.78 .74 
 Tension .57 .64 
 Hypersomnia (L) .50 .54 
 Impulsive (L) .63 .71 
 Anger (L) .85 .83 
 Fault-finding/Unpleasant (L)  .79 .82 
 Impatience (L) .81 .82 
 Worrisome (L) .75 .75 
 Feelings of loss of control (L) .70 .72 
 Body dissatisfaction (L) .43 .55 
 Easy to lose temper (L) .80 .81 
    
Factor 2: Somatic Distress 15.8% 17.6% 
 Take naps, stay in bed .57 .62 
 Abdominal cramps .75 .74 
 Dizziness, faintness .58 .65 
 Backache .49 .43 
 Fatigue .64 .62 
 Nausea, vomiting .50 .59 
 Stomachache .77 .75 
 Weakness (L) .55 .64 
 Paleness (L) .44 .64 
    
Factor 3: Cognitive Problems 11.8% 17.6% 
 Confusion .57 .50 
 Lowered judgment .72 .59 
 Blurred vision, blindspots .59 .47 
    
Factor 4: Arousal 11.8% 7.0% 
 Excitement .51 .48 
 Affectionate .44 .40 
 Orderliness .62 .61 
 Feelings of well-being .89 .91 
 Bursts of energy, activity .90 .86 
Note: % refer to the amount of total variance accounted for by the respective factors; (L) 
denotes local items that were not in the original MDQ 
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Table 3. Comparison of Premenstrual versus Intermenstrual and Menstrual 
versus Intermenstrual CQ-PERI-MS Subscale Scores in Study 1 (n = 538). Values are 
given as mean [SD]   
 
CQ-PERI-MS 
Subscales 
Premenstrual 
(P) 
Menstrual 
(M) 
Intermenstrual 
(I) 
P 
(P vs I) 
 
P 
(M vs I) 
      
Dysphoria 1.65 [.89] 1.85 [.92] 1.29 [.63] <.001 <.001 
      
Somatic Distress 1.54 [.71] 2.02 [.88] 1.21 [.45] <.001 <.001 
      
Cognitive Problems 1.15 [.46] 1.24 [.56] 1.08 [.35] <.001 <.001 
      
Arousal 1.53 [.79] 1.41 [.68] 1.72 [.90] <.001 <.001 
Note: P vs I represent Premenstrual Changes, M vs I represent Menstrual Changes 
 
 27 
Table 4.  Table showing correlations of premenstrual symptoms and menstrual 
symptoms,with anxiety, depression, and neuroticism.  
 Anxiety Depression Neuroticism 
Premenstrual     
Dysphoria .20** .10* .18** 
Somatic Distress .19** .11** .14** 
Cognitive Problems .20** .11* .11** 
Arousal NS NS NS 
Menstrual    
Dysphoria .30** .14** .30** 
Somatic Distress .24** .09* .25** 
Cognitive Problems .26** .15** .18** 
Arousal NS NS .10* 
Note: * p < .05; ** p < .01, NS not significant
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Table 5. Percentage of participants (n = 339) experiencing ten or more, fifteen 
or more, and twenty or more premenstrual and menstrual symptoms (Study 2).  
 
 
 Premenstrual Menstrual 
10 or more symptoms 63 (18.6) 116 (34.2) 
15 or more symptoms 25 (7.4) 60 (17.7) 
20 or more symptoms 10 (2.9) 21 (6.2) 
 
Note: Values are given as n (%). 
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Table 6. Percentage of Participants Reporting Premenstrual and Menstrual 
Symptoms (n = 339) 
  Premenstrual Menstrual 
Factor 1:   Dysphoria   
 Loneliness   7.6% 12.8% 
 Anxiety   
   
24.0% 26.8% 
 Irritability   
  
39.9% 54.4% 
 Mood swings   
  
32.5% 47.1% 
 Depressed mood  
  
26.8% 34.9% 
 Tension 19.4% 27.3% 
 Hypersomnia (L) 18.5% 37.1% 
 Impulsive (L) 11.6% 14.9% 
 Anger (L) 22.5% 32.7% 
 Fault-finding/Unpleasant (L)  17.2% 24.8% 
 Impatience (L) 24.7% 37.8% 
 Worrisome (fan nao) (L) 23.3% 31.6% 
 Feelings of loss of control (L) 11.3% 12.8% 
 Body dissatisfaction (L) 10.9% 14.6% 
 Easy to lose temper (L) 31.5% 40.7% 
    
Factor 2: Somatic Distress   
 Take naps, stay in bed 21.3% 45.1% 
 Abdominal cramps 33.6% 60.6% 
 Dizziness, faintness 14.7% 25.7% 
 Backache 25.5% 36.0% 
 Fatigue 36.4% 62.0% 
 Nausea, vomiting 8.2% 10.8% 
 Stomachache (L) 36.2% 54.3% 
 Weakness (xu yue) (L) 18.2% 31.8% 
 Paleness (L) 12.9% 43.8% 
    
Factor 3: Cognitive Problems   
 Confusion 4.0% 9.8% 
 Lowered judgment 8.6% 15.6% 
 Blurred vision, blindspots 5.1% 7.7% 
    
Factor 4: Arousal   
 Excitement 7.0% 6.6% 
 Affectionate 3.0% 4.3% 
 Orderliness 4.8% 7.5% 
 Feelings of well-being 7.5% 7.9% 
 Bursts of energy, activity 4.2% 4.2% 
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Table 7. Comparison of CPDQ Subscale Symptom Severity Scores in the 
Premenstrual, Menstrual, and Intermenstrual Phases in Study 2 (n = 339) using 
Repeated Measures ANOVA and Planned Post Hoc Comparisons.  
 
CPDQ Subscale Premenstrual 
(P) 
Menstrual 
(M) 
Intermenstrual 
(I) 
 Planned Post Hoc Comparisons 
P (P vs I) P (M vs I) P (P vs M) 
Dysphoria 1.54 [.77] 1.66 [.80] 1.24 [.50] < .001 < .001 < .001 
       
Somatic 
Distress 
1.53 [.66] 1.85 [.80] 1.25 [.47] < .001 < .001 < .001 
       
Cognitive 
Problems 
1.19 [.50] 1.26 [.61] 1.11 [.33] < .001 < .001 < .001 
       
Arousal 1.34 [.59] 1.33 [.60] 1.21 [.47)] < .001 < .001 < .001 
 
Note:  Values are given as mean [SD]. 
 
 
